Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article. IJRMCS. 2024;2(02):20-30. doi:10.70829/ijrmcs.v2.i2.0724002